Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience

Abstract

Talimogene laherparepvec is a well-tolerated, durable treatment option for patients with unresectable locoregional melanoma, particularly in stage IIIB/C disease. Additionally, we found that TVEC can be administered safely across anatomic sites that are otherwise not amenable to other local therapies.